Related Experiment Video
Updated: Dec 29, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Directional Atherectomy of the Common Femoral Artery: Complications and Outcomes
Fernando Picazo1, Ricky C H Kwok1, Joseph A Hockley1
1Department of Vascular and Endovascular Surgery, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
Insights
Directional atherectomy (DA) with drug-coated balloons (DCB) shows promise for common femoral artery (CFA) occlusive disease. Initial results indicate safety and effectiveness, with high patency rates and manageable complications.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapy
Background:
- Common femoral artery (CFA) occlusive disease management often involves minimally invasive techniques.
- Directional atherectomy (DA) with or without drug-coated balloons (DCB) offers advantages like early mobilization and reduced complications.
- However, DA has recognized complications, potentially linked to the learning curve.
Purpose of the Study:
- To present initial experience with DA for CFA occlusive disease.
- To suggest practice-based improvements for better outcomes.
- To evaluate the safety and efficacy of DA with/without DCB in CFA treatment.
Main Methods:
- Retrospective analysis with prospective data collection from two centers.
- Inclusion of 25 consecutive patients undergoing CFA DA with/without DCB for >70% stenosis.
- Primary endpoints: technical success, primary patency, morbidity, mortality. Secondary endpoints: Rutherford-Becker class, length of stay, revascularization rate.
Main Results:
- 25 patients underwent CFA DA; 23 had >70% stenosis.
- No 30-day deaths. Complications: 2 pseudoaneurysms, 1 perforation (all managed).
- 100% primary and secondary patency at 3-6 months, 96% at 12 months. Mean LOS 1.9 days.
Conclusions:
- CFA DA with/without DCB appears safe and effective in early outcomes.
- Pre-procedural imaging (CTA, USS) may help minimize risks like pseudoaneurysm or perforation.
- Procedural experience is crucial for preventing long-term complications like localized dilatation.
Background:
The use of directional atherectomy (DA) with or without drug-coated balloon (DCB) may be considered for the management of common femoral artery (CFA) occlusive disease because of its minimally invasive nature with early mobilization, reduced incision complications, and infection rates. However, it has recognized complications, which may be related to the learning curve. We present our initial experience using DA and suggest changes that may, based on our practice, improve outcomes.
Methods:
Retrospective analysis with a prospective data collection from 2 centers to analyze outcomes in all consecutive patients treated during 1 year (n = 25). Patients who underwent CFA DA with/without DCB for CFA >70% stenosis. Primary end points include technical success, primary patency of the CFA, morbidity, and mortality. Secondary end points include change in Rutherford-Becker class, length of stay, and target lesion revascularization rate.
Results:
Between July 2017 and December 2018, 25 patients underwent CFA DA. Two had an occluded CFA, and 23 had >70% CFA stenosis as determined by ultrasound scan (USS) and/or computed tomography angiogram (CTA) preoperatively. There were no deaths within 30 days. Procedure-related complications included 2 cases of CFA pseudoaneurysm (one of them repaired by open surgery) and 1 CFA perforation (repaired with covered stent). No distal embolization or limb loss occurred. Mean length of stay was 1.9 days. Primary and secondary patency at 3 and 6 months was 100%. At 12 months, it was 96%.
Conclusions:
Early results suggest that CFA DA with/without DCB is safe and effective. Previous CTA, focused USS, and/or intravascular USS may be useful to minimize the risk of pseudoaneurysm or perforation by excessive thinning of the media. Experience is required to prevent localized dilatation over time.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiac Catheterization III: Left Heart Catheterization
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Cardiac Catheterization IV: Nursing Management
Aneurysm III: Interprofessional Care